Table 5 Effect of ethanolic Moringa oleifera extract, ethyl acetate fraction, and hexane fraction on mRNA expression of apoptosis markers (BCL-2 and BAX).

From: Bioactivity-guided analysis of Moringa olifera fractionated extracts for potential medical application

Sample

GAPDH

BAX

BCL2

 

CT

CT

Fold change

CT

Fold change

Liver carcinoma

20.43

22.95

20.68

Liver carcinoma + ethanolic extract

20.81

20.16

9.0005

22.04

0.5070

Liver carcinoma + ethyl acetate fraction

19.72

19.83

5.3147

20.29

0.8011

Liver carcinoma + hexane fraction

19.54

18.44

12.2950

21.95

0.2238

Breast carcinoma

19.25

21.89

20.14

Breast carcinoma + ethanolic extract

18.47

17.59

11.4716

20.87

0.3511

Breast carcinoma + ethyl acetate fraction

19.62

19.62

6.2333

21.22

0.6113

Breast carcinoma + hexane fraction

18.58

17.21

19.1113

23.56

0.0587

Pancreatic carcinoma

20.11

23.14

21.71

Pancreatic carcinoma + ethanolic extract

19.24

20.13

4.4076

21.68

0.5586

Pancreatic carcinoma + ethyl acetate fraction

20.18

22.10

2.1585

22.09

0.8066

Pancreatic carcinoma + hexane fraction

20.56

20.52

8.3977

23.27

0.4633